第一单位：
Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
作者：
Holly,Lee [1]
;
Sungwoo,Ahn [1]
;
Gerone A,Gonzales [2]
;
Noemie,Leblay [1]
;
Elie,Barakat [1]
;
Dylan,Greening [3]
;
Pina,Colarusso [3]
;
Johnathan,Canton [2]
;
Sacha,Benaoudia [1]
;
Elham,Hasheminasabgorji [1]
;
Mansour,Poorebrahim [1]
;
David,Jung [1]
;
Marietta,Truger [4]
;
Jihong,Jeong [5]
;
Christine,Riedhammer [6]
;
Hermann,Einsele [6]
;
K Martin,Kortüm [6]
;
Jan,Eckmann [7]
;
Jitka,Somandin [8]
;
Sara-Sheena,Engel [9]
;
Lawrence H,Boise [10]
;
Jan Hendrik,Frenking [11]
;
Niels,Weinhold [11]
;
Konstantina,Taouxi [12]
;
Efstathios,Kastritis [12]
;
Sheri,Skerget [13]
;
Deeksha,Vishwamitra [13]
;
Yunje,Cho [5]
;
Francesco,Maura [14]
;
Marc S,Raab [11]
;
Jill,Corre [15]
;
Leo,Rasche [6]
;
Hervé,Avet-Loiseau [16]
;
Paola,Neri [1]
;
Nizar J,Bahlis [17]
作者单位：
Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada.
[1]
Faculty of Veterinary Medicine, University of Calgary, Calgary, Alberta, Canada.
[2]
Department of Physiology and Pharmacology and the Live Cell Imaging Laboratory, Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada.
[3]
MLL Munich Leukemia Laboratory, Munich, Germany.
[4]
Department of Life Science, Pohang University of Science and Technology, Pohang, South Korea.
[5]
Department of Internal Medicine 2, University Hospital of Würzburg, Würzburg, Germany.
[6]
Discovery Oncology, Roche Pharma Research and Early Development, Roche Innovation Center, Munich, Germany.
[7]
Roche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, Switzerland.
[8]
Laboratory for Hematological Diagnostics, MVZ, Heppenheim, Germany.
[9]
Department of Hematology and Medical Oncology, Emory School of Medicine, and the Winship, Cancer Institute of Emory University Atlanta, Atlanta, GA, USA.
[10]
Heidelberg Myeloma Center, Department of Medicine V, Heidelberg University Hospital and Medical Faculty, Heidelberg, Germany.;CCU Molecular Hematology/Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[11]
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
[12]
Johnson & Johnson, Spring House, PA, USA.
[13]
Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
[14]
University of Toulouse, University Hospital, Unit for Genomics in Myeloma, IUCT Oncopole, CRCT, Toulouse, France.
[15]
Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France.
[16]
Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Alberta, Canada. nbahlis@ucalgary.ca.
[17]
DOI
10.1038/s41591-025-04175-8
PMID
41540108
发布时间
2026-05-20
换一批
